ABSTRACT
O ur overarching aim was to design an instrument to measure general ophthalmic pain severity, which would also be suitable for our specific research purpose of assessing pain relief outcomes of corneal transplantation. Corneal transplantation for pain relief is important as indicated by the Australian Corneal Graft Registry in which 73% of the corneal grafts registered were performed to improve vision, and 19% to relieve eye pain. 1 Improvement in vision as a corneal graft outcome is effectively assessed using the standard clinical measures of visual performance, [2] [3] [4] but ophthalmic pain relief had not been formally assessed using an eye-specific instrument.
Many different types of scales have been developed to measure pain, including visual analogue scales and various categorical scales using faces, numbers, or verbal categorical descriptors. [5] [6] [7] [8] However, no pain scale specific to ophthalmic pain has been developed and validated using focus groups and Rasch analysis. The majority of previous investigators have used general pain scales to measure pain after ophthalmic procedures or the impact of treatments for ophthalmic pain. 9 -21 The only designated ophthalmic pain scale is the two-item pain subscale of the National Eye Institute Visual Function Questionnaire-25. 22, 23 However, the National Eye Institute Visual Function Questionnaire pain scale has not been developed with any statistical validity e.g., factorial validity; it has poor psychometric properties, [22] [23] [24] [25] [26] [27] and does not hold up under Rasch analysis. 28, 29 Ideally, an instrument should be developed and validated on ophthalmic patients to ensure optimal specificity and sensitivity to change in ophthalmic pain. Good psychometric properties including valid interval scoring are also important. Therefore, we set out to develop such an instrument.
It was envisaged that this instrument would be administered in the clinical setting by eye care practitioners and was developed for use both in research and as a clinical tool for measuring ophthalmic pain. Because of the time constraints of the clinical setting the instrument had to be brief and relatively easy to administer. We used focus groups to explore how ophthalmic pain was described by those who had or were experiencing ophthalmic pain. Our specific goal was to develop a scale of pain severity, and we therefore sought information on the appropriate number of scale categories and their descriptors, as well as how ophthalmic pain was described more generally, from these discussions. We used this qualitative data to ensure incorporation of all important features of ophthalmic pain that needed to be considered in order to be able to design an instrument that could adequately measure ophthalmic pain severity.
METHODS Setting
The focus groups were held in the conference room of the ophthalmology service of Flinders Medical Centre (The Flinders Eye Centre), Adelaide, South Australia.
Ethical Approval
Ethical approval for this study was gained from the Flinders Clinical Research Committee before commencement. Detailed study information was given to potential participants before gaining written consent from those who wished to be involved. This study adhered to the tenets of the Declaration of Helsinki.
Participants
Participants for the focus groups were purposively sampled from The Flinders Eye Centre. Eligibility criteria included experience of ophthalmic pain (past or current), 18 years of age or over, English conversational skills sufficient for free participation in the focus group discussions, and sufficient cognitive function for informed consent. Ophthalmologists and clinic staff ascertained eligible participants from the Flinders Eye Centre patient population. The focus group participants were from a wide range of socioeconomic and ethnic backgrounds, and lived within a 50-km radius of the Flinders Eye Centre.
The age and gender characteristics of the participants, and the eye conditions causing ophthalmic pain, were representative of Flinders Eye Centre adult patients who had experienced ophthalmic pain, including corneal graft candidates and recipients (Table  1) . Among participants, the most common cause of ophthalmic pain was either recurrent corneal erosions or rejection of a corneal graft. The types of eye conditions causing ophthalmic pain experienced by participants included typical pain indications for corneal graft surgery.
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Recruitment
Eligible patients were screened in a brief telephone interview, and those who were willing to be involved in the focus group discussions were appointed to a session. Aiming for six to eight participants per group, 23 patients were approached with 15 agreeing to participate (65%). This resulted in four to six participants per group, a number at the lower end of what is considered satisfactory for focus groups participation. 30 A follow-up letter, study information sheet, consent form, and demographic form were sent to each participant before their focus group. Participants were asked to bring the completed forms to their focus group session. Each participant was offered a small monetary gift to assist with traveling or parking expenses.
Data Collection
Focus groups are a standard methodological approach for identifying questionnaire content directly from the target population. They have the advantages of providing richness of data and enhancing recall through participant interaction with minimal facilitator influence. Three 1-to 2-hour focus group sessions were held over a period of 3 months. These sessions were audio-recorded, and verbatim person-specific transcriptions were produced and independently reviewed by two researchers after each session. Subsequent focus group protocols were modified to explore important emergent themes and issues. Data collection ceased when no new themes or issues were evident and content saturation was thought to have occurred. The final instrument was evaluated using a mailout questionnaire to all focus group participants in which they were asked the following questions: 1. In your opinion, does the severity scale of the Eye Sensation Scale, with its choices of "extreme," "severe," "moderate," "mild," or "none" allow you to adequately describe the intensity or severity of the eye pain/sensations you have experienced? (yes/no-if "no," please explain); 2. Do you think that the Eye Sensation Scale, as it currently exists, allows you to adequately describe the pain/sensation you have experienced? (yes/no-if "no," please explain).
Focus Group Protocols and Topics
The focus groups were facilitated by Lynda Caudle who has had previous experience in conducting focus groups. A high degree of participation was encouraged from all focus group members. The focus group protocol proceeded from general unguided query about the eye pain participants had experienced, to issues, and exercises specific to development of the eye pain scale. Moderator bias was managed by following recommended focus group moderation techniques, i.e., minimize moderator interaction with focus group participants by encouraging participants to interact with each other, and by responding to participants in an impartial way only when necessary to encourage participation and further clarification/description. 30 The preferred category descriptors and the number of nonredundant response categories required to adequately capture participants' ophthalmic pain experience were explored using different methods as described in Fig. 1 . Prototype pain severity scales were designed based on previously published scales and data were collected in the focus groups. 8, [31] [32] [33] [34] A verbal rating scale (a set of categories with named descriptors) was selected as these types of scales are easy for a majority of people to use. [35] [36] [37] Given that previous research has shown that scales with many (e.g., 7 to 10) categories suffer from underutilized or overlapping response categories, 38 -40 we conjectured that four or five categories would be sufficient for ophthalmic pain measurement and initially trialled prototypes of this size. Examples of the pain severity scales used to assess scale response patterns and preferences used in the last focus group are shown in Fig. 2 .
Analyses
The focus group transcripts were reviewed independently by two researchers and all comments relating to ophthalmic pain were identified and examined for dominant themes. Identified comments about ophthalmic pain were then coded according to these themes, and were analyzed further for any subdomains or divergent themes.
Relative frequencies of the broad domains and subdomains were then produced. In this way, the participants' experience of ophthalmic pain, and more importantly, the way they tended to describe their ophthalmic pain was captured, with the salient features identified. This also provided a vignette of how each participant conceptualized their own ophthalmic pain. Discourse analytic features of the participants' descriptions were also examined, revealing frequent use of similes or metaphors, "negative" descriptions or what the pain was not, and the use of external criteria or standards.
Participant responses to the focus group exercises, such as ordering of descriptors according to increasing severity of ophthalmic pain, and participant response patterns and scale preferences were used to assess the optimal number of nonredundant response categories and preferred category descriptors for the final instrument.
RESULTS
Descriptions of ophthalmic pain from the focus group data suggested five broad descriptive domains of intensity, nature (including subdomains of physical sensation, temporal patterning, and simile/metaphor subdomains), and physical, emotional, and behavioral effects. As the participants were asked to describe their ophthalmic pain without further specification in the main, the relative frequencies of the descriptors and domains indicated their relative importance. Physical sensation descriptors were the most frequently mentioned aspect of ophthalmic pain (n ϭ 160). When the simile/metaphor nature subdomain descriptors (n ϭ 44) and the temporal patterning descriptors (n ϭ 22) were added to the physical sensation descriptors, the nature domain became by far the most prominent domain with 220 nature references ( Table 2) . Behavioral effects of pain were the next most frequently mentioned aspect (n ϭ 87), followed by the severity descriptors (n ϭ 75), and the physical effects of pain (n ϭ 68) (Tables 3 and 4) . Emotional effects were the least mentioned descriptors with 23 references. As can be seen from the relative frequencies, participants tended to describe the nature of their pain, and how the pain affected their lives (behavioral effects). Severity descriptors tended to not be used when describing ophthalmic pain, unless specifically requested.
The high frequency of the use of alternate words to "pain" such as "uncomfortable" and "discomfort" indicated that the scale should not be referred to, or titled, simply as a "pain scale," but should be more properly titled a "Pain and Discomfort Scale" to reflect the importance of these alternate words in describing ophthalmic pain. This was further supported by several participants (both men and women) who repeatedly explained that the painful sensation they had experienced in their eyes was "not pain," but rather "discomfort." These participants viewed "pain" as distinct from ophthalmic painful sensations, in that they regarded "pain" as the painful sensation they experienced when "hitting their thumb with a hammer," "cutting themselves," or other types of somatic pain that they described as sharp, immediate, and intense. These participants used these examples to explain that they would not refer to their ophthalmic sensations as "pain," but rather as "dis- comfort." For example, one participant persisted in talking about his pain as a discomfort even though he was taking Panadeine Forte [paracetamol (Acetaminophen) 500 mg, codeine 30 mg] for pain relief. He repeatedly referred to this pain as "not pain" but a "major discomfort." As a consequence of these explanations of ophthalmic pain, the scales presented to participants in focus group 3 ( Fig. 2) were titled "Pain and Discomfort Scale" to encompass these findings and avoid participants not using the scale because they did not regard their sensation as pain.
It was also evident from the focus group dialogues, that participants tended to describe the pain (if experiencing more than one type concomitantly) or aspects of their pain that bothered them the most, whether it be how their pain felt (nature), how it affected themselves and their lives (physical and behavioral effects) or how they felt about their pain (emotional effects). The participants also tended to describe their pain at its worst intensity, and did not tend to talk about how it increased/decreased, unless specifically asked to talk about how the pain developed or behaved over time.
Apparent gender differences in the description of ophthalmic pain included the pain comparatives used to illustrate their pain. For instance, several women compared the ophthalmic pain they had experienced to being worse or not as bad as the pain of childbirth, whereas men used pain comparatives such as "hitting their thumb with a hammer," breaking bones or dislocating joints, or cutting themselves. Further exploration of gender differences in the description of ophthalmic pain were not explored as participant numbers were not considered sufficient.
Subjective and cultural elements also seemed to be operating in participants' descriptions of their ophthalmic pain. Participants, both men and women, tended to "talk down" the severity of their pain, even though it was evident that their pain was significant, i.e., taking Panadeine Forte for pain relief, or not being able to move about or open their eyes because of their pain. Several of these participants referenced what they appeared to view as generally held cultural norms when talking about their pain, such as "You have to just put up with it, don't you?"
Thematic Analysis of Severity Domain Descriptors
The descriptors used to indicate severity of ophthalmic pain are shown in Table 3 . The frequencies of alternate words to "pain", Whenever "ache"/"aching" was used alone it was classified as a nature descriptor rather than a "pain" substitute. Whenever severity descriptors were associated with "ache"/"aching" these were also counted in the severity descriptor frequencies.
"Light sensitivity" listed under physical sensations refers to light sensitivity synonymous with pain, rather than being an effect of pain as listed in Table 4 . such as "uncomfortable," "discomfort," "sore," or "soreness" are indicated separately if not used together with a severity descriptor. Higher frequency severity descriptors included "extreme", "very," "severe," "excruciating," "intense," "moderate," and "mild," and these were considered as candidates for the category labels of the final scale.
Thematic Analysis of Domains Other Than Severity
The descriptors participants used for the nature, (including physical sensation and temporal patterning), and the physical, emotional, and behavioral effects of ophthalmic pain are shown in Tables 2 and 4 . Analysis of the nature descriptors indicated that participants most commonly described the nature of their painful experience in terms of its physical sensation and temporal patterning. Corresponding subdomains were therefore created, including a further subdomain of simile and metaphor, given the frequency with which participants used these to describe the nature of their pain. The physical sensation of pain was by far the most frequently mentioned aspect of the nature of their pain (n ϭ 204), including the simile/metaphor subdomain, and comparatively, temporal patterning was rarely mentioned (n ϭ 22) ( Table 2) . It was also evident that some participants had experienced concomitant pain of differing nature and/or severity, i.e., such as brief periods of sharp, stabbing pain against a background of continuous pain of a different nature and severity, such as a dull generalized ache or "gritty/sand-in-your-eye" sensations. This has implications for how patients should be instructed to make pain ratings and this was taken into account in the design of the final instrument.
Light sensitivity was often experienced concomitantly with pain, and participants variously described this as a type of pain and/or a cause or exacerbation of pain, as well as a physical or behavioral effect of pain. Several participants talked about light sensitivity as a significant problem which they hoped could be alleviated. Certainly for some subjects, photophobia was seen to be indistinguishable from pain. We reflected this in the scales piloted in focus group 3 by requesting assessment of not simply "pain" or "discomfort" but "eye sensations." The title of the finalized scale was also changed to reflect this and became the "Eye Sensation Scale."
With respect to the effects of pain, participants mentioned behavioral effects more frequently (n ϭ 87), than physical (n ϭ 68) and emotional effects (n ϭ 23) ( Table 4 ). These behavioral effects included references to what they did to alleviate pain, coping behaviors, what they could not do because of their pain, and what they were still able to do despite their pain.
Category Response Analyses Using Various Scales
The response category choices and scale preferences of participants in focus group 3 are shown for three successively presented scales (Fig. 2) . The category selections of participants C and B across the successive scales indicated that an intermediate category of "severe" should exist between "extreme/excruciating" and "moderate."
Response category choices between the four-category scales and the five-category scale confirmed the adequacy of the lower scale categories from "none" to "moderate." As can be seen, participants A and C continued to choose "moderate" rather than moving up to "severe" thereby providing evidence for stability of this descriptor within the scale structure. Likewise, participants B, C, D, and E also remained with the descriptor "mild" across the successive scales, suggesting the adequacy of category levels from "none" to "moderate."
The third scale presented with five categories ranging from "none" to "extreme/excruciating" was preferred by all the participants and participant choices showed good utilization of all the categories with no apparent redundancy.
The Final Eye Sensation Scale
The final Eye Sensation Scale (Fig. 3) was developed directly from the findings of the focus group data as described above. The preamble of the instrument, (to be read to the patient before completing the scale) is very important as it outlines the painful eye sensations the scale is intended to measure (i.e., sensations conceptualized/described as "pain," "discomfort," "light sensitivity," or any other descriptor synonymous with pain), as well as the time period over which to recall these sensations. The patient is then requested to only assess the sensation that bothered them the most if they had experienced multiple sensations, and asks them to rate its severity using one of five categories on the severity scale ("none," "mild," "moderate," "severe," and "extreme"). They are also asked to only assess the severity of the sensation when present, rather than averaging the severity level over periods of no sensation, as occurs with cyclical or intermittent sensations. Varying severity of the sensation being assessed, such as when the painful sensation increases or decreases in severity over appreciable time periods, is also addressed by requesting the patient to estimate an average level.
Evaluation of the Scale by the Focus Group Participants
Fifty-six percent of participants responded to mail-out evaluation of the Eye Sensation Scale. All answered yes to both questions: 1. In your opinion, does the severity scale of the Eye Sensation Scale, with its choices of "extreme," "severe," "moderate," "mild," or "none" allow you to adequately describe the intensity or severity of the eye pain/sensations you have experienced?; 2. Do you think that the Eye Sensation Scale, as it currently exists, allows you to adequately describe the pain/sensation you have experienced? Many participants made further comments: "Like the way it's done and the more options"; "It's a good scale. It evaluates light sensitivity as pain"; "Light sensitivity has been debilitating, but I was still able to cope. While the next level up-being "extreme"-it would mean that I was not coping at all! I think the scale does work!" This last comment indicates people incorporate their level of coping into their assessment of level of pain or eye sensationthis is indicated by the high frequency of references to behavioral aspects of pain mentioned by participants. Therefore, the severity scale, and the instrument overall, was adequate for assessing their painful eye sensations.
DISCUSSION
The experience of ophthalmic pain is subjective, personal, complex, and emotive; even so, significant commonalties in how participants described their pain exist and were important in designing an ophthalmic pain scale that was relevant and meaningful. Because participants variously described different painful eye sensations, the final ophthalmic pain instrument incorporated sensations described as "pain," "discomfort," "light sensitivity," and any other eye sensations related to ophthalmic comfort. Previous investigators working on the development of general pain scales have also noted the reluctance of some people to describe their experience as "pain." 41 In this way, eye sensations such as light sensitivity, that some subjects described as light sensitivity but conceptualized as a pain or discomfort, will be assessed by the instrument.
A five-category scale was chosen to assess eye sensation severity as indicated by the participants' scale preferences and category choices. The performance of five categories will be tested using Rasch analysis once sufficient pilot data are available. The utility of a five-category pain severity scale has also been shown in previous work, in which the scale performance of a five-category scale was shown to be superior to a seven-category scale, after elimination of category redundancy and overlap using Rasch analysis. 39, 40 A 1-month time period was proposed to capture multiple episodes of ophthalmic pain of differing nature in accordance with the focus group participants' experience of intermittent episodes of ophthalmic pain, however, the time period for assessment could be varied depending upon the indication for instrument usage. The scale assessment specifies consideration of only the eye sensation that bothered them the most during the 1-month time period. This was specified in the scale because several focus group participants had experienced multiple types of concomitant pain, and it appeared from the focus group data that the type of pain that bothered them the most was most salient, in that they tended to recall and give more detailed description of this pain and did not tend to discuss the other types of pain experienced unless prompted. The choice of pain "that bothers them the most" is likely to be based on the more the frequent pain descriptor domains taken from the focus group data, such as the nature of the pain, including its temporal qualities, or its effect on their lives (behavioral effects). Because some eye sensations were intermittent or increased/decreased over time, the final instrument assessed average severity of the sensation while present, rather than averaging over periods of no sensation. Thus the instructions for scoring the severity rating of the Eye Sensation Scale are lengthy, however, clarification of these temporal issues are important to the ability of the scale to measure pain outcomes of corneal graft surgery or other ophthalmic interventions.
Participants preferred to describe the nature of their pain in some detail rather than simply report its severity, unless specifically requested. Furthermore, several participants commented that it was important to have a sense that the pain they were experiencing had been well understood by those treating them. Answering questions about severity or being asked to indicate only pain severity was considered to be insufficient. An apparent need to give a fuller account of their painful experience has also been found by others. For example Warms et al. discovered in their survey study of spinal cord injury or amputation pain that providing space for free comment was important, given the number of comments participants wrote in the margins of their questionnaire about the pain they were experiencing. 42 It seems that people suffering pain feel that they are the experts on pain and that it is difficult to communicate effectively with their medical practitioners about their pain. Clearly it was important for participants to be able to describe their unique and subjective experience of ophthalmic pain. The provision of a free response section apart from the intensity/severity scale was a way to fulfill this need, while still keeping the instrument brief.
Comparison of the more commonly used ophthalmic pain nature descriptors (Table 2 ) with nature descriptors used to describe arthritic, labor, cancer, and phantom limb pain, and toothache 43 revealed several descriptors that were unique to ophthalmic pain, such as "grittiness," "irritation," "light sensitivity," "stinging," "raw," "scratchy/scratchiness," and "niggling." Conversely, commonalities were also found, such as "aching/ache," "sharp," and "throbbing." Scaling of the severity of each of these descriptors, as in the intensity scaling of nature descriptors in the short-from McGill Pain Questionnaire, 44 and as well, scaling of their temporal characteristics using the temporal patterning descriptors (Table 2) indicating continuous sensation, such as "constant," "continuous," "persistent," or "perpetual" (n ϭ 19), or "intermittent" (n ϭ 3) sensation could have been used in this instrument. This would have produced a more detailed measure of all the painful eye sensations experienced within the limitations of recall, but would not have indicated which painful sensation the patient would most like to have alleviated, for example, with corneal graft surgery. This may cause problems in outcomes measurement where the "signal" from the important sensation score may be lost in the "noise" from the other sensation scores. The Eye Sensation Scale, although limited in detailed assessment of the overall pain experienced, does however, assess the intended outcome, while still maintaining the brevity required for clinical administration by eye care practitioners.
It was also evident that individual participants had their own unique understanding or conceptualization of their eye pain, including what causes it, and what makes it better or worse. More importantly, these beliefs and conceptualizations gained from experience seemed to direct their pain self-management, such as, when they would seek medical attention or take analgesics. It was also apparent from several participants' comments, that using analgesics to relieve ophthalmic pain had not been considered, as they believed the nature of the pain they were experiencing would not be relieved by pain killers. This finding may be important to treating eye care practitioners when considering pain relief options for their patients.
This presentation of focus group findings represents the first phase of the development of an instrument to measure ophthalmic pain severity. The data collected in this way are limited by factors such as difficulty of recall of pain. 45 Although the initial evaluation of the instrument suggests validity, piloting the instrument designed herein is critical to the full development of the instrument. Although qualitative data from our focus groups suggests that a five-category scale with four levels of pain would be optimal for measuring ophthalmic pain severity, testing of the instrument using Rasch analysis will be carried out on pilot data. Rasch analysis will provide assessment of utilization of the scale categories, including category redundancy, independence, or overlap, 39, 46 and if indicated, will be used to revise and improve the instrument. 47 This should result in a valid and reliable pain severity scale for use in ophthalmic patients with particular relevance to corneal and anterior segment pain.
